We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated May 20, 2022, relating to the consolidated financial statements of Cend Therapeutics,
Inc. appearing in Registration Statement No. 333-265638 on
Form S-4, Amendment No. 1, of Lisata Therapeutics, Inc. (formerly
Caladrius Biosciences, Inc.).